About
Focus
Pipeline
Investors
Contact
More
May 19, 2020
Timber Pharmaceuticals, Inc., (NYSE American: TMBR), formerly known as BioPharmX Corporation ("Timber" or the "Company"), a biopharmaceutical...
May 12, 2020
Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of...
April 6, 2020
Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development...
January 28, 2020
Two privately held biotechs on Tuesday announced plans for reverse mergers, transactions that provide a faster...
July 5, 2019
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) has reached an out-licensing and development agreement with US-based Timber Pharmaceuticals [Timber] for...
BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") and Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical...